No Data
No Data
No Data
No Data
No Data
Coya Therapeutics to Participate in the Mizuho Neuroscience Summit
Coya Therapeutics, Inc. (NASDAQ:COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) function, announces that Chief Executive Officer
BusinesswireApr 22 20:15
Coya Therapeutics to Participate in the 3rd Annual ALS Drug Development Summit
Coya Therapeutics, Inc. (NASDAQ:COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) function, announces that President and Chief
BusinesswireApr 18 20:15
Coya Therapeutics Scientific Advisory Board Chairman Dr. Stanley Appel to Present Updated ALS Biomarker Data at the 2nd Annual Johnson Center Symposium
Coya Therapeutics, Inc. (Nasdaq: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) function, announces that Dr. Stanley Appel, M.D., Chairman of Coya's Scientific Advisory Board, and Dr. David Beers, Ph.D., Associate Research Professor of Neurology, Houston Methodist, will present updated ALS biomarker data at the upcoming 2nd Annual Johnson Center Symposium in Houston, Texas on April 26, 2024. The title of the poster is 4-hydroxynonenal (4-HNE) as a Biomarker in ALS.
BusinesswireApr 8 20:15
We're Not Very Worried About Coya Therapeutics' (NASDAQ:COYA) Cash Burn Rate
Yahoo FinanceMar 27 20:37
Coya Therapeutics Inc (COYA) Reports Fiscal 2023 Financial Results and Corporate Updates
Yahoo FinanceMar 21 17:31
Analysts Offer Insights on Healthcare Companies: Healthequity (HQY), Coya Therapeutics, Inc. (COYA) and Iovance Biotherapeutics (IOVA)
TipRanksMar 20 18:01
No Data
No Data